Gemini Bio产品代理

Since its   inception in 1985, Gemini Bio’s focus and niche has always been to produce consistent, high   quality products, coupled with exceptional, personalized service. The company   began operations in Calabasas, California, with marketing activities   targeting the research and biotech community across the state. As a result of   continued and progressive success, Gemini consistently expanded the sales   force to be able to service the entire United States.

Today, Gemini is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific 

community   across academic research and the biotechnology, cell and gene therapy, and   biopharma industries. A national sales force and an international   distribution network serves cell culture laboratories worldwide.

In September   2018, BelHealth Investment Partners, a healthcare private equity firm,   invested in Gemini Bio. A new leadership team led by CEO Dale Gordon was   brought on to guide the company through its exciting next chapter. With this   growth investment, Gemini moved into a new state-of-the-art 25,000 square   foot facility in West Sacramento in 2020. Gemini Bio is an ISO 13485   certified, FDA registered Class 1 Medical Device Manufacturer, aligned with   21 CFR Part 820.

Throughout its growth, Gemini has maintained the personalized service on which its reputation was built. Samples and orders are often processed and shipped the same day they are requested, enabling customers to receive their orders the very next day. Gemini’s sales team visits customers regularly to provide mutually agreed solutions to customer needs. Today, we are proud of what we uniquely offer at Gemini: competitively priced products, extensively tested and proven to be of high quality over the last 36 years, combined with exceedingly unbeatable service within the industry.